Drugs Made In America Acquisition Corp. Stock (DMAA)
Track Drugs Made In America Acquisition Corp. stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
DMAA
Drugs Made In America Acquisition Corp.
healthcare
$10.60
▲ +0.48 (+4.74%) past year
Market Cap
$257.58M
P/E Ratio
30.6x
1Y Return
+4.74%
EPS (TTM)
$0.20
Read the latest TheStreet Pro articles mentioning Drugs Made In America Acquisition Corp., including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning DMAA yet.
Daily Diary Mentions
0 mentionsNo diary mentions for DMAA yet.